We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVA icon
1126
Avista
AVA
$3.24B
$542K 0.01%
12,699
+6,443
+103% +$295K
BJ icon
1127
BJs Wholesale Club
BJ
$12.3B
$541K 0.01%
11,375
-7,598
-40% -$348K
EXR icon
1128
Extra Space Storage
EXR
$31.6B
$541K 0.01%
3,300
-15,645
-83% -$2.34M
POWI icon
1129
Power Integrations
POWI
$3.61B
$538K 0.01%
6,560
+854
+15% +$69K
FCN icon
1130
FTI Consulting
FCN
$4.18B
$536K 0.01%
3,925
+2,201
+128% +$310K
MCB icon
1131
Metropolitan Bank Holding Corp
MCB
$1.15B
$536K 0.01%
8,902
+8,331
+1,459% +$507K
SYNH
1132
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$536K 0.01%
5,979
-10,121
-63% -$855K
BHVN
1133
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$536K 0.01%
5,520
+1,278
+30% +$104K
CABO icon
1134
Cable One
CABO
$212M
$534K 0.01%
279
+93
+50% +$167K
PCG icon
1135
PG&E
PCG
$38.5B
$530K 0.01%
52,124
-3,085
-6% -$33.1K
WLY icon
1136
John Wiley & Sons Class A
WLY
$2.66B
$530K 0.01%
8,805
+821
+10% +$48.8K
MSA icon
1137
Mine Safety
MSA
$7.49B
$529K 0.01%
3,197
+729
+30% +$118K
RETL icon
1138
Direxion Daily Retail Bull 3X ETF
RETL
$29.7M
$529K 0.01%
+10,890
New +$477K
RVTY icon
1139
Revvity
RVTY
$12.8B
$529K 0.01%
3,424
-7,747
-69% -$1.09M
TENB icon
1140
Tenable Holdings
TENB
$4.01B
$529K 0.01%
12,801
+2,233
+21% +$90.6K
KEY icon
1141
KeyCorp
KEY
$24.4B
$528K 0.01%
25,551
-86,380
-77% -$1.88M
NVEE
1142
DELISTED
NV5 Global
NVEE
$527K 0.01%
22,288
+19,776
+787% +$450K
ENS icon
1143
EnerSys
ENS
$6.99B
$526K 0.01%
5,380
+382
+8% +$35.6K
KKR icon
1144
KKR & Co
KKR
$92.3B
$526K 0.01%
8,883
-25,117
-74% -$1.39M
YUMC icon
1145
Yum China
YUMC
$16.3B
$526K 0.01%
7,948
+1,811
+30% +$116K
DEN
1146
DELISTED
Denbury Inc.
DEN
$526K 0.01%
6,844
+6,628
+3,069% +$404K
IVOV icon
1147
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.36B
$525K 0.01%
+6,488
New +$531K
MGM icon
1148
MGM Resorts International
MGM
$11.2B
$525K 0.01%
12,308
-33,084
-73% -$1.37M
PSB
1149
DELISTED
PS Business Parks, Inc.
PSB
$525K 0.01%
3,540
-505
-12% -$79.4K
DISCK
1150
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$525K 0.01%
18,125
-648
-3% -$20.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.